Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the ...

Cipla announced that it filed two generic respiratory drug applications with the US FDA in the last quarter, including a generic version of Symbicort and one other undisclosed inhalation product.

Cipla share will remain in focus on Thursday ... Afrezza is a rapid-acting insulin delivered through an inhaler as compared to current insulins which are given as injections.

After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

Drugmaker Cipla expects its “diversified” business in the US to help sustain its growth ... On the new US administration’s possible tariffs on pharmaceuticals, Vohra said, the company had invested ...

In 1978, Cipla started manufacturing of Metered-Dose Inhaler (MDI). 1984 was the year when the company name was changed from The Chemical, Industrial & Pharmaceutical Laboratories to Cipla Limited.

It has also notified extension of separate ceiling price of IV fluids in special packaging and separate ceiling price for Cipla's Synchrobreathe inhaler, following a latest Authority meeting. The ...